← back to search

David S. Snyder

University of Alabama at Birmingham · US
🔎 Find collaborators in Hematology · Public Health, Environmental and Occupational Health →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research focused on Myeloid leukemia and Chronic myelogenous leukemia, with related work in Essential thrombocythemia, Myelofibrosis, Leukemia. Notable publications include 'Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology', 'Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology', and 'Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia'.
h-index
—
citations
1,658
works
15
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2020cited by 265position: middledoi
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2020cited by 52position: middledoi
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Biology of Blood and Marrow Transplantation 2019cited by 35position: middledoi
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2018cited by 281position: middledoi
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
Nature Medicine 2018cited by 162position: middledoi
Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2018cited by 104position: middledoi
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
Journal of the National Comprehensive Cancer Network 2017cited by 151position: middledoi
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017
Journal of the National Comprehensive Cancer Network 2016cited by 85position: middledoi
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia
Haematologica 2016cited by 49position: middledoi
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
New England Journal of Medicine 2015cited by 197position: lastdoi
Historical Views, Conventional Approaches, and Evolving Management Strategies for Myeloproliferative Neoplasms
Journal of the National Comprehensive Cancer Network 2015cited by 31position: middledoi
Chronic Myelogenous Leukemia, Version 1.2015
Journal of the National Comprehensive Cancer Network 2014cited by 71position: middledoi
Chronic Myelogenous Leukemia, Version 1.2014
Journal of the National Comprehensive Cancer Network 2013cited by 83position: middledoi
Phase <scp>II</scp> trial of panobinostat, an oral pan‐deacetylase inhibitor in patients with primary myelofibrosis, post–essential thrombocythaemia, and post–polycythaemia vera myelofibrosis
British Journal of Haematology 2013cited by 69position: middledoi
Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results
Blood 2012cited by 23position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel J. DeAngelo · Harvard University3 papers (2013–2014)Ellin Berman · Weill Cornell Medicine2 papers (2013–2014)Arnel Pallera · University of Alabama at Birmingham2 papers (2013–2014)Michael W. Deininger · University of Wisconsin–Milwaukee2 papers (2013–2014)Steven M. Devine · Memorial Sloan Kettering Cancer Center2 papers (2013–2014)Amir T. Fathi · University of Southern California2 papers (2013–2014)Neil P. Shah · University of California, San Francisco2 papers (2013–2014)Vishnu Reddy · University of Alabama at Birmingham2 papers (2013–2014)Jessica K. Altman · Northwestern University2 papers (2013–2014)— · 2 papers (2012–2015)Meir Wetzler · University of Colorado Denver2 papers (2013–2014)Benjamin D. Smith · Edward Via College of Osteopathic Medicine2 papers (2013–2014)— · 2 papers (2012–2015)— · 2 papers (2012–2015)Olatoyosi Odenike · Leipzig University2 papers (2012–2015)Patricia Kropf · University of Colorado Denver2 papers (2013–2014)Jason Gotlib · University of California, San Francisco2 papers (2013–2014)Madan Jagasia · Vanderbilt University Medical Center2 papers (2013–2014)— · 2 papers (2012–2015)Camille N. Abboud · Washington University in St. Louis2 papers (2013–2014)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hematology · Public Health, Environmental and Occupational Health →